IRIS
ZULIANI, Valentina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.844
AS - Asia 2.495
EU - Europa 2.194
SA - Sud America 281
AF - Africa 131
Totale 7.945
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.759
SG - Singapore 808
CN - Cina 775
VN - Vietnam 410
FI - Finlandia 390
IT - Italia 385
SE - Svezia 284
IE - Irlanda 262
DE - Germania 245
BR - Brasile 221
UA - Ucraina 204
HK - Hong Kong 200
GB - Regno Unito 88
NL - Olanda 84
FR - Francia 79
ZA - Sudafrica 71
BD - Bangladesh 67
RU - Federazione Russa 60
CA - Canada 58
TR - Turchia 58
IN - India 47
CI - Costa d'Avorio 23
BE - Belgio 22
AT - Austria 19
IQ - Iraq 19
JP - Giappone 16
MX - Messico 16
KR - Corea 15
PH - Filippine 15
CZ - Repubblica Ceca 14
AR - Argentina 12
EC - Ecuador 12
ES - Italia 12
PK - Pakistan 12
PL - Polonia 12
LT - Lituania 9
MA - Marocco 9
VE - Venezuela 9
CO - Colombia 8
EG - Egitto 8
ID - Indonesia 8
TH - Thailandia 8
CL - Cile 7
PT - Portogallo 6
KE - Kenya 5
PE - Perù 5
TN - Tunisia 5
IR - Iran 4
NP - Nepal 4
AE - Emirati Arabi Uniti 3
BO - Bolivia 3
PY - Paraguay 3
SA - Arabia Saudita 3
TW - Taiwan 3
AL - Albania 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BY - Bielorussia 2
CR - Costa Rica 2
EE - Estonia 2
ET - Etiopia 2
HU - Ungheria 2
JM - Giamaica 2
JO - Giordania 2
MY - Malesia 2
NI - Nicaragua 2
PR - Porto Rico 2
PS - Palestinian Territory 2
QA - Qatar 2
RO - Romania 2
SI - Slovenia 2
SN - Senegal 2
SY - Repubblica araba siriana 2
UZ - Uzbekistan 2
AM - Armenia 1
BF - Burkina Faso 1
BH - Bahrain 1
BW - Botswana 1
CY - Cipro 1
DZ - Algeria 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
LB - Libano 1
LI - Liechtenstein 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MU - Mauritius 1
OM - Oman 1
PA - Panama 1
RS - Serbia 1
ZW - Zimbabwe 1
Totale 7.945
Salva come PNG Salva come JPEG
Città #
Singapore 421
Ashburn 318
Chandler 279
Dublin 262
San Jose 258
Jacksonville 214
Hong Kong 189
Beijing 183
Santa Clara 155
Dallas 151
Ho Chi Minh City 120
Ann Arbor 119
Dearborn 101
Boardman 99
Hanoi 99
Nanjing 83
Parma 80
Munich 79
New York 77
Los Angeles 72
Johannesburg 70
Hefei 58
Princeton 51
Shanghai 51
Lauterbourg 47
Milan 47
Helsinki 44
Izmir 41
San Mateo 40
Toronto 36
Wilmington 35
Moscow 29
Turku 29
Frankfurt am Main 26
Bremen 25
Shenyang 24
Abidjan 23
Hebei 23
Buffalo 22
Nanchang 22
Brussels 21
Jinan 21
São Paulo 21
Kunming 19
Vienna 19
Da Nang 18
Columbus 17
Council Bluffs 17
Seattle 17
London 16
Guangzhou 15
Tokyo 15
Des Moines 14
Seoul 14
Brooklyn 12
Chennai 12
Jiaxing 12
Phoenix 12
The Dalles 12
Woodbridge 12
Haiphong 11
Modena 11
Ankara 10
Bologna 10
Houston 10
Montreal 10
Orem 10
Reggio Emilia 10
Tianjin 10
Changsha 8
Warsaw 8
Auburn Hills 7
Baghdad 7
Chicago 7
Norwalk 7
Nuremberg 7
Pune 7
Rome 7
Amsterdam 6
Atlanta 6
Brno 6
Chengdu 6
Denver 6
Jakarta 6
Mexico City 6
Piacenza 6
Redondo Beach 6
Belo Horizonte 5
Bengaluru 5
Falkenstein 5
Genoa 5
Guayaquil 5
Haikou 5
Hangzhou 5
Manchester 5
Marseille 5
Poplar 5
Quito 5
Reggio Nell'emilia 5
Stockholm 5
Totale 4.694
Salva come PNG Salva come JPEG
Nome #
2-Aminobenzimidazoles as new potent H3-antagonists 225
5-Benzylidene-hydantoins as new EGFR inhibitors with antiproliferative activity 206
5-Benzylidene-hydantoins: synthesis and antiproliferative activity on A549 lung cancer cell line 203
3D proteome-wide scale screening and activity evaluation of a new ALKBH5 inhibitor in U87 glioblastoma cell line 198
Synthesis, biological activity, QSAR and QSPR study of 2/aminobenzimidazole derivatives as potent H3-antagonists 198
NEW ALKBH2 AND ALKBH5 INHIBITORS FOR TREATING GLIOBLASTOMA 196
Aminobenzimidazoles as new potent H3-antagonists 196
The Role of HB-Donor Groups in the Heterocyclic Polar Fragment of H3-Antagonists. I. Synthesis and Biological Assays 183
5-benzylidene-hydantoins as new inhibitors of cell proliferation 179
Cognition enhancing effect in rats of a selected histamine H3 receptor antagonist with good brain penetration 178
5-benzylidene-hydantoin UPR 1024 acts as EGFR inhibitor and induces DNA damage in A549 NSCLC cell line 178
Access to CNS of selected H3-antagonists: ex vivo binding study in rats 177
Antiproliferative and proapototic effects of a new combi-molecule on non small cell lung cancer cell lines 177
QSAR study of 2-aminobenzimidazole derivatives as H3 antagonists 159
Meccanismo d’azione di UPR 1024: un nuovo farmaco con attività antiproliferativa in cellule di carcinoma polmonare umano 158
A Short and Efficient Synthesis of the Selective H4 Receptor Agonist 4-Methylhistamine 157
Access to CNS of selected H3-antagonists: ex vivo binding study in rats 156
Chiral NMR discrimination of the diastereoisomeric salts of the H(3)-antagonist 2-[3-(1H-imidazol-4-ylmethyl)piperidin-1-yl]-1H-benzimidazole. 155
MV1035 Overcomes Temozolomide Resistance in Patient-Derived Glioblastoma Stem Cell Lines 153
2,4(5)-Diarylimidazoles: Synthesis and Biological Evaluation of a New Class of Sodium Channel Blockers against hNav1.2 150
New ALKBH2 and ALKBH5 inhibitors for treating glioblastoma 149
Synthesis and 3D-QSAR Analysis of H3 Receptor Antagonists Containing a Neutral Heterocyclic Polar Group 149
Advances in Design and Development of Sodium Channel Blockers. 149
2,4(5)-Diarylimidazoles as Inhibitors of hNaV1.2 Sodium Channels: Pharmacological Evaluationand Structure-Property Relationships 147
Dual mechanisms of action of the 5-benzylidene-hydantoin UPR1024 on lung cancer cell lines 147
CNS access of selected H3-antagonists: ex vivo binding study in rats 144
Anticonvulsant Activity of 2,4(5)-Diarylimidazoles in Mice and Rat Models 142
Anticonvulsant Activity of 2,4(1H)-Diarylimidazoles in Mice and Rats Acute Seizure Models 142
Development of a GPCR model for SAR interpretation of classical and new H3 antagonists 141
Biological evaluation of imidazobenzoxazines, imidazobenzoxazin-5-ones and imidazobenzoxazin-5-thiones as sodium channel blockers 139
Synthesis and biological evaluation of new non-imidazole H(3)-receptor antagonists of the 2-aminobenzimidazole series 138
Novel Sodium Channel Antagonists in the Treatment of Neuropathic Pain 137
Synthesis and biological assays of new H3-antagonists with imidazole and imidazoline polar groups 137
Discovery of antitubercular 2,4-diphenyl-1H-imidazoles from chemical library repositioning and rational design 132
Histamine H3-antagonists: the basicity of the polar group in quantitative structure-activity and structure-property relationship 130
Three-Dimensional Quantitative Structure-Activity Relationship Studies on Selected MT1 and MT2 Melatonin Receptor Ligands: Requirements for Subtype Selectivity and Intrinsic Activity Modulation 129
Drug repurposing approaches to fight Dengue virus infection and related diseases 127
Potential in-vitro antiviral activity of MV1035 on SARS-CoV-2 wild type viruses 120
Relationship between structure and ex-vivo binding of imidazole H3 antagonists to rat brain H3 receptors 117
In vivo Screening of Diarylimidazoles as Anticonvulsant Agents 115
Inhibition of NaV1.6 sodium channel currents by a novel series of 1,4-disubstituted-triazole derivatives obtained via copper-catalyzed click chemistry 114
IMIDAZOBENZOXAZIN-5-THIONE (MV1035) TO OVERCOME THE BLOOD-BRAIN BARRIER AND TARGET CNS DISEASES 113
NMR Analysis of a Series of Imidazobenzoxazines 112
A Practical Synthesis of 2,4(5)-Diarylimidazoles from Simple Building Blocks 111
Structure-Property Relationships on Histamine H3-Antagonists: Binding of Phenyl-substituted Alkylthioimidazole Derivatives to Rat Plasma Proteins 108
Imidazole H3-antagonists: Relationship between Structure and Ex-vivo binding to Rat Brain H3-Receptors 108
Sodium Channel Blocking Activity and In-vivo Testing of New Phenyl-imidazole Derivatives. 108
Microwave Assisted Efficient Synthesis of Imidazole-based Privileged Structure 104
Sodium channel blockers for neuropathic pain. 104
Recent Advances in the Medicinal Chemistry of Sodium Channel Blockers and their Therapeutic Potential 103
Sodium channel blockers: a patent review (2010 - 2014) 101
Synthesis and stability in biological media of 1H-imidazole-1-carboxylates of ROS203, an antagonist of the histamine H3 receptor. 98
Sodium Channel Blockers as Therapeutic Target for Treating Epilepsy: Recent Updates 96
Fluorescent Ligands for the Histamine H2 Receptor: Synthesis and Preliminary Characterization 76
pH-partition profiles of 4-(3-oxo-1,2-benzisothiazolin-2-yl)phenyl and phenoxyalkanoic acids 74
Recent advances in the discovery of ALKBH 1–8 inhibitors. 67
Erratum: Fluorescent ligands for the histamine H 2 receptor: Synthesis and preliminary characterization (Bioorganic & Medicinal Chemistry (2004) 12 (6495-6503)) 66
null 36
Totale 8.012
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.500
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.500
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215 0 0 0 0 0 0 0 0 0 0 0 5
2021/2022251 2 5 6 20 11 8 33 35 15 18 27 71
2022/20231.103 119 120 83 76 101 143 19 46 322 16 40 18
2023/2024400 14 41 13 11 39 96 40 23 17 23 31 52
2024/20251.386 56 83 101 115 67 143 52 84 108 131 151 295
2025/20263.142 270 327 357 330 404 200 364 84 371 265 110 60
Totale 8.012